Aikido pharma inc. (SPEX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues

-

-

-

-

-

-

-

-

-

284

314

311

327

314

314

177

72

-

-

-

2

1

2

3

4

19

2

0

6

3

16

0

0

-

-

186

306

368

327

Operating costs and expenses
Amortization of patent portfolio

-

-

-

-

-

378

346

343

338

346

346

343

338

537

536

531

531

-

-

-

2,422

2,478

2,476

2,449

2,428

133

134

0

0

-

-

-

-

-

-

-

-

-

-

Rent

-

-

-

-

-

-

-

-

-

22

21

27

22

19

20

23

22

22

22

22

22

655

71

71

67

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Depreciation expense

-

-

-

-

-

-

-

-

-

-

1

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3

5

16

-

0

-

-

-

-

-

-

-

-

Acquisition costs

-

-

-

66

-

-

-

66

145

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

1,303

1,468

892

99

713

2,512

554

116

142

120

137

174

62

65

65

60

63

-

-

-

226

717

92

51

836

-2,886

2,789

661

446

-1,170

542

530

692

513

417

685

932

933

1,230

Amortization of patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Compensation and related expenses (including stock-based compensation)

-

-

-

175

-

-

-

342

355

688

488

294

589

441

836

361

312

-

-

-

719

1,177

1,799

7,202

3,532

2,654

6,393

281

455

-

0

-

-

-

-

-

-

-

-

Revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of patent portfolio

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

722

2,450

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Compensation and related expenses (including stock-based compensation)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

336

-54

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs of goods sold

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Gross profit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

Direct costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

119

130

121

112

Research and development

85

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-617

107

138

371

514

371

404

355

1,453

1,544

Research and development - license acquired

1,011

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development - license acquired

-

-

10

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Professional fees

-

-

-

548

-

-

-

395

597

223

280

250

285

421

343

824

705

713

787

551

729

828

726

1,816

1,150

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Impairment of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

37,212

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of intangible assets

-

-

-

-

-

-

1,051

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

92

122

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

2,399

3,191

902

888

713

2,112

1,951

1,262

1,577

1,401

1,273

1,088

1,296

4,196

1,800

1,799

1,633

5,663

1,959

40,303

4,118

5,855

5,164

11,589

8,013

4,191

9,319

947

917

1,108

650

668

1,063

778

788

1,209

1,418

2,509

2,886

Loss from operations

-2,399

-3,182

-902

-888

-713

-2,084

-1,951

-1,262

-1,577

-1,117

-959

-777

-969

-3,882

-1,486

-1,622

-1,561

-5,632

-1,959

-40,303

-4,116

-5,854

-5,162

-11,586

-8,009

-4,172

-9,317

-947

-911

-1,105

-633

-668

-1,063

-1,270

-788

-1,022

-1,111

-2,140

-2,559

Other expenses
Gains and (losses) on marketable securities

-863

-

-

-

92

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expenses), net

-

-

-33

-28

-

-108

-35

-93

-97

-8

6

121

172

-223

16

55

-30

-

-

-

30

-

-

-

46

-

37

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of investment

-5,071

4,171

-2,435

145

-475

-

-

680

-

-

345

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

0

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities

-

-1

-7

-127

53

-180

-95

-277

-188

-139

-1,067

1,204

122

-202

-1,024

511

-1,542

-

-

-

0

-

-1

-7

-

8

-37

-139

2,786

-

-

-

-

-

-

-

-

-

-

Other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

-5

-

-

17

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-774

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expenses

-5,934

4,155

-2,461

244

-436

7,586

60

864

91

131

1,418

-1,083

50

-21

1,040

-456

1,512

1,287

-767

-5

30

-3

18

18

46

-

-

140

-2,786

-

-

-

-

-

-

-

-

-

-

Unrealized (loss) gain on the change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-339

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1

0

0

0

1

1

2

Fair value adjustments for warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

58

342

-

-

-

-

-

-

-

Loss from continuing operations before taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

574

325

723

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

0

8

44

-

-

Gain on settlement of obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,690

0

0

845

-

-

(Loss) income from continuing operations before taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,440

-787

-1,013

-220

-2,139

-2,557

Income tax expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,264

-574

-325

-723

-

-

-

-

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-787

-

-

-

-

Loss from discontinued operations before taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-133

-79

-110

-

-125

-

-

-

-

Income tax expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-14

0

0

14

-

-

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-645

-133

-79

-110

-

-125

-

-

-

-

Net loss

-8,333

973

-3,363

-644

-1,149

5,502

-1,891

-398

-1,486

-986

459

-1,860

-919

-3,903

-446

-2,078

-49

-4,345

-2,726

-40,308

-4,086

-5,857

-5,144

-11,568

-7,963

-4,181

-9,280

-807

-3,697

-1,910

-707

-404

-834

-

-

-

-

-

-

Deemed capital contribution on extinguishment of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-667

0

-31,480

667

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed capital contribution on extinguishment of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,236

-446

29,402

-716

4,817

-2,726

-40,308

-4,086

-

-

-

-

-

-

-

-

-

-

-

-

-

-913

-1,013

-235

-2,139

-

Net loss per share, basic and diluted
Continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6.15

-

-

-

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.98

-

-

-

-

Basic and Diluted

-0.91

-

-1.38

-

-0.57

-

-0.94

-

-0.96

-

-

-0.38

-0.19

-

-

-

-0.26

-

-

-

-2.71

-26.88

-0.18

-0.69

-1.66

-0.22

-6.93

-1.14

-5.35

-

-

-

-

-

-7.13

-

-

-

-

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.11

9.61

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2.76

-1.56

-3.89

-

-

-

-

-

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.64

-0.38

-0.59

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,557

Basic

-

-

-

-0.30

-

-

-

-0.20

-

-

0.08

-

-

-

-

-

-

-

-1.56

-26.76

-

-

-

-

-

-

-

-

-

-

-3.40

-1.95

-4.48

-

-

-0.40

-0.10

-1.25

-1.49

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.11

9.21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted

-

-

-

-0.30

-

-

-

-0.20

-

-

0.08

-

-

-

-

-

-

-

-1.56

-26.76

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.40

-0.10

-1.25

-1.49

Weighted average number of shares outstanding, basic and diluted
Basic and Diluted

9,195

-

2,442

-

2,010

-

2,010

-

1,549

-

-

4,958

4,943

-

-

-

2,705

-

-

-

1,505

-45,581

28,065

16,879

4,789

2,533

1,339

705

691

-

-

-

-

-

128

-

-

-

-

Basic

-

-

-

2,124

-

-

-

2,008

-

-

5,998

-

-

-

4,163

3,060

-

-

1,744

1,506

-

-

-

-

-

-

-

-

-

-

207

207

186

-

-

2,562

2,448

1,715

1,715

Diluted

-

-

-

2,124

-

-

-

2,008

-

-

6,009

-

-

-

4,163

3,193

-

-

1,744

1,506

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,562

2,448

1,715

1,715